355
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Serum reference value of two potential doping candidates—myostatin and insulin-like growth factor-I in the healthy young male

, , &

References

  • McPherronACLawlerAMLeeSJRegulation of skeletal muscle mass in mice by a new TGF-β superfamily memberNature1997387 83 90 1:CAS:528:DyaK2sXivFygur0%3D 10.1038/387083a0 9139826
  • ZimmersTADaviesMVKoniarisLGHaynesPEsquelaAFTomkinsonKNMcPherronACWolfmanNMLeeSJInduction of cachexia in mice by systemically administered myostatinScience2002296 1486 1488 1:CAS:528:DC%2BD38XktFanu7o%3D 10.1126/science.1069525 12029139
  • SchuelkeMWagnerKRStolzLEHubnerCRiebelTKomenWBraunTTobinJFLeeS-JMyostatin mutation associated with gross muscle hypertrophy in a childN Engl J Med2004350 2682 2688 1:CAS:528:DC%2BD2cXltFGns7c%3D 10.1056/NEJMoa040933 15215484
  • DielPSchifferTGeislerSHertrampfTMoslerSSchulzSWintgensKFAdlerMAnalysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCRMol Cell Endocrinol2010330 1 9 1:CAS:528:DC%2BC3cXht1Ogur3F 10.1016/j.mce.2010.08.015 20801187
  • AdamsGRHaddadFBodellPWTranPDBaldwinKMCombined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in ratsJ Appl Physiol2007103 1644 1654 1:CAS:528:DC%2BD2sXhtlyrtr%2FK 10.1152/japplphysiol.00669.2007 17872405
  • RothSMMartelGFFerrellREMetterEJHurleyBFRogersMAMyostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communicationExp Biol Med2003228 706 709 1:CAS:528:DC%2BD3sXmvFOrurk%3D
  • WalkerKSKambadurRSharmaMSmithHKResistance training alters plasma myostatin but not IGF-1 in healthy menMed Sci Sports Exerc200436 787 793 1:CAS:528:DC%2BD2cXkvFaju7k%3D 10.1249/01.MSS.0000126384.04778.29 15126711
  • AdamsGRMcCueSALocalized infusion of IGF-I results in skeletal muscle hypertrophy in ratsJ Appl Physiol199884 1716 1722 1:CAS:528:DyaK1cXjsVOksbk%3D 9572822
  • RommelCBodineSCClarkeBARossmanRNunezLStittTNYancopoulosGDGlassDJMediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathwaysNat Cell Biol20013 1009 1013 1:CAS:528:DC%2BD3MXosVeqt7w%3D 10.1038/ncb1101-1009 11715022
  • ShyuKGKoWHYangWSWangBWKuanPInsulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytesCardiovasc Res200568 405 414 1:CAS:528:DC%2BD2MXht1SqsrrI 10.1016/j.cardiores.2005.06.028 16125157
  • LiuWThomasSGAsaSLGonzalez-CadavidNBhasinSEzzatSMyostatin is a skeletal muscle target of growth hormone anabolic actionJ Clin Endocrinol Metabol200388 5490 5496 1:CAS:528:DC%2BD3sXptVyntL4%3D 10.1210/jc.2003-030497
  • HanDSChenYMLinSYChangHHHuangDMChiYCYangWSSerum myostatin levels and grip strength in normal subjects and patients on maintenance hemodialysisClin Endocrinol (Oxf)201175 857 863 1:CAS:528:DC%2BC3MXhs1GksbzL 10.1111/j.1365-2265.2011.04120.x
  • AzzazyHMEMansourMMHChristensonRHDoping in the recombinant era: strategies and counterstrategiesClin Biochem200538 959 965 1:CAS:528:DC%2BD2MXht1SqsL%2FE 10.1016/j.clinbiochem.2005.09.007 16286094
  • BartonERMorrisLMusaroARosenthalNSweeneyHLMuscle-specific expression of insulin-like growth factor I counters muscle decline in mdx miceJ Cell Biol2002157 137 148 1:CAS:528:DC%2BD38Xis1Knsb8%3D 10.1083/jcb.200108071 11927606 2173262
  • BogdanovichSKragTOBBartonERMorrisLDWhittemoreLAAhimaRSKhuranaTSFunctional improvement of dystrophic muscle by myostatin blockageNature2002420 418 421 1:CAS:528:DC%2BD38XptFCisrs%3D 10.1038/nature01154 12459784
  • ChangK-VHungC-YLiC-MLinY-HWangT-GTsaiK-SHanD-SReduced flexibility associated with metabolic syndrome in community-dwelling eldersPLoS One201510 e0117167 10.1371/journal.pone.0117167 25614984 4304714
  • ChienM-YHuangT-YWuY-TPrevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in TaiwanJ Am Geriatr Soc200856 1710 1715 10.1111/j.1532-5415.2008.01854.x 18691288
  • SallisJSeven-Day physical activity recallMed Sci Sports Exerc199729 89 103
  • SallisJFHaskellWLWoodPDFortmannSPRogersTBlairLAIRSNPaffenbargerRSPhysical activity assessment methodology in the five-city projectAm J Epidemiol1985121 91 106 1:STN:280:DyaL2M%2FmvFCksA%3D%3D 3964995
  • WintgensKFDschietzigTStoevaSPaulssonMArmbrusterFPPlasma myostatin measured by a competitive ELISA using a highly specific antiserumClin Chim Acta2012413 1288 1294 1:CAS:528:DC%2BC38XmvFKlsLY%3D 10.1016/j.cca.2012.04.023 22561185
  • JuC-RChenR-CSerum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary diseaseRespir Med2011106 102 108 10.1016/j.rmed.2011.07.016 21840694
  • ZamoraESimóRLupónJGalánAUrrutiaAGonzálezBMas†DValleVSerum myostatin levels in chronic heart failureRev Esp Cardiol (Engl Version)201063 992 996 10.1016/S0300-8932(10)70212-8
  • LakshmanKMBhasinSCorcoranCCollins-RacieLATchistiakovaLForlowSBLedgerKBurczynskiMEDornerAJLaVallieERMeasurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administrationMol Cell Endocrinol2009302 26 32 1:CAS:528:DC%2BD1MXis1ertbw%3D 10.1016/j.mce.2008.12.019 19356623
  • FeldmanBJStreeperRSFareseRVYamamotoKRMyostatin modulates adipogenesis to generate adipocytes with favorable metabolic effectsProc Natl Acad Sci U S A Biol Sci2006103 15675 15680 1:CAS:528:DC%2BD28XhtFCisrzM 10.1073/pnas.0607501103
  • KimHSLiangLDeanRGHausmanDBHartzellDLBaileCAInhibition of preadipocyte differentiation by myostatin treatment in 3 T3-L1 culturesBiochem Biophys Res Commun2001281 902 906 1:CAS:528:DC%2BD3MXhs1Churo%3D 10.1006/bbrc.2001.4435 11237745
  • EhehaltSSchweizerRBlumenstockGPfaffCSchurrNWeberKRankeMBBinderGInvestigation of myostatin serum levels before and after a 6-month lifestyle intervention program in obese childrenExp Clin Endocrinol Diabetes2011119 238 242 1:CAS:528:DC%2BC3MXms1Wls7o%3D 10.1055/s-0030-1267964 21104587
  • BhattSPNigamPMisraAGuleriaRLuthraKJainSKQadar PashaMAAssociation of the myostatin gene with obesity, abdominal obesity and Low lean body mass and in Non-diabetic Asian Indians in north IndiaPLoS One20127 e40977 1:CAS:528:DC%2BC38Xht1GnsrvO 10.1371/journal.pone.0040977 22916099 3423417
  • HanD-SChu-SuYChiangC-KTsengF-YTsengP-HChenC-LWuK-DYangW-SSerum myostatin is reduced in individuals with metabolic syndromePLoS One20149 e108230 10.1371/journal.pone.0108230 25254550 4177900
  • HillJDaviesMVPearsonAAWangJHHewickRMWolfmanNWQiuYThe myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serumJ Biol Chem2002277 40735 40741 1:CAS:528:DC%2BD38XnvFyntb0%3D 10.1074/jbc.M206379200 12194980
  • MatsakasABozzoCCaccianiNCaliaroFReggianiCMascarelloFPatrunoMEffect of swimming on myostatin expression in white and red gastrocnemius muscle and in cardiac muscle of ratsExp Physiol200691 983 994 1:CAS:528:DC%2BD28XhtlGhsL7F 10.1113/expphysiol.2006.033571 16873457
  • SharmaMKambadurRMatthewsKGSomersWGDevlinGPConaglenJVFowkePJBassJJMyostatin, a transforming growth factor-?superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarctJ Cell Physiol1999180 1 9 1:CAS:528:DyaK1MXjs1Cgs7Y%3D 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V 10362012
  • MahmoudabadyMMathieuMDewachterLHadadIRayLJespersPBrimioulleSNaeijeRMcEnteeKActivin-a, transforming growth factor-[beta], and myostatin signaling pathway in experimental dilated cardiomyopathyJ Card Fail200814 703 709 1:CAS:528:DC%2BD1cXhtFOrtLjI 10.1016/j.cardfail.2008.05.003 18926443
  • HoenigMRHypothesis: myostatin is a mediator of cardiac cachexiaInt J Cardiol2008124 131 133 10.1016/j.ijcard.2007.07.058 17905451
  • PetersDBarashIABurdiMYuanPSMathewLFridénJLieberRLAsynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the ratJ Physiol2003553 947 957 1:CAS:528:DC%2BD2cXosVSqsg%3D%3D 10.1113/jphysiol.2003.048462 14514871 2343611
  • HoltRIGErotokritou-MulliganIMcHughCBassettEEBartlettCFityanABaconJLCowanDASönksenPHThe GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletesEur J Endocrinol2010163 45 54 1:CAS:528:DC%2BC3cXpsFeju7o%3D 10.1530/EJE-09-0978 20421332
  • TentoriLGrazianiGDoping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?Pharmacol Res200755 359 369 1:CAS:528:DC%2BD2sXkt1aqsrw%3D 10.1016/j.phrs.2007.01.020 17349798
  • NeuhouserMLDiCTinkerLFThomsonCSternfeldBMossavar-RahmaniYStefanickMLSimsSCurbJDLamonteMSeguinRJohnsonKCPrenticeRLPhysical activity assessment: biomarkers and self-report of activity-related energy expenditure in the WHIAm J Epidemiol2013177 576 585 10.1093/aje/kws269 23436896 3626043
  • AinsworthBEHaskellWLHerrmannSDMeckesNBassettDRJTudor-LockeCGreerJLVezinaJWhitt-GloverMCLeonAS2011 compendium of physical activities: a second update of codes and MET valuesMedicine & science in sports & exercise2011 1575 1581